Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cytokine ; 6(1): 48-54, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8003633

RESUMO

Oncostatin M (OSM) is a cytokine which shares a common gene structure and amino acid sequence similarity with leukemia inhibitory factor (LIF), granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6), suggesting evolution from a common ancestral gene. These four cytokines share several biological activities including the ability to induce the differentiation of the murine M1 myeloid leukemic cell line. To further define the functional similarities within this family, we have investigated whether OSM can substitute for LIF in the maintenance in vitro of the undifferentiated state of pluripotent embryonic stem (ES) cells. In this study, we demonstrate that human recombinant OSM is similar to LIF in its ability to inhibit the differentiation of MBL-5 murine ES cells cultured in vitro. The level of differentiation was determined by morphological criteria and by the continued expression of the embryonic stem cell-specific surface antigen defined by the ECMA-7 monoclonal antibody. Competition binding studies demonstrate that OSM binds to the LIF receptor on MBL-5 ES cells. Our results implicate OSM as a developmental regulatory factor for embryonic stem cells in vivo.


Assuntos
Antígenos de Superfície/biossíntese , Diferenciação Celular/efeitos dos fármacos , Citocinas/farmacologia , Inibidores do Crescimento , Interleucina-6 , Linfocinas , Peptídeos/farmacologia , Células-Tronco/citologia , Animais , Anticorpos Monoclonais , Antígenos de Superfície/análise , Ligação Competitiva , Evolução Biológica , Blastocisto , Linhagem Celular , Citocinas/genética , Cinética , Fator Inibidor de Leucemia , Subunidade alfa de Receptor de Fator Inibidor de Leucemia , Camundongos , Oncostatina M , Peptídeos/genética , Peptídeos/metabolismo , Receptores de Citocinas/metabolismo , Receptores de OSM-LIF , Células-Tronco/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...